Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fu-Sheng Wang

Showing results (31-40 of 429) with videos related to

Pageof 43
Sort By:
Hepatology International|November 1, 2023
Why is the functional cure rate of young children with chronic hepatitis B receiving antiviral therapy considerably high?Fu-Sheng Wang, Jing Li, Chao Zhang
Cellular & Molecular Immunology|November 7, 2020
Neutrophils in liver diseases: pathogenesis and therapeutic targetsKai Liu, Fu-Sheng Wang, Ruonan Xu
The Lancet. Gastroenterology & Hepatology|March 8, 2020
Liver injury in COVID-19: management and challengesChao Zhang, Lei Shi, Fu-Sheng Wang
Alimentary Pharmacology & Therapeutics|January 10, 2024
Letter: Baseline age on antiviral treatment may significantly influence the clinical response of children with chronic hepatitis BJing Li, Yaxin Wu, Fu-Sheng Wang
Cellular & Molecular Immunology|December 14, 2011
Liver fibrosis: mechanisms of immune-mediated liver injuryRuonan Xu, Zheng Zhang, Fu-Sheng Wang
The New England Journal of Medicine|March 27, 2004
SARS-associated coronavirus quasispecies in individual patientsDongping Xu, Zheng Zhang, Fu-Sheng Wang
Infectious Diseases & Immunity|April 17, 2024
The Progress and Challenges of Convalescent Plasma Therapy for Coronavirus Disease 2019Ming Shi, Chao Zhang, Fu-Sheng Wang
Infectious Diseases & Immunity|June 22, 2026
Viral persistence in long COVID: Research advances and treatment strategiesShiyang Liu, Yuming Guo, Fu-Sheng Wang
The Lancet. HIV|June 1, 2020
COVID-19 in people with HIVZhe Xu, Chao Zhang, Fu-Sheng Wang
Ebiomedicine|March 13, 2022
Mesenchymal stem cell treatment for COVID-19Ruonan Xu, Zhiqian Feng, Fu-Sheng Wang
Pageof 43

Showing results (31-40 of 429) with videos related to

Sort By:
Pageof 43
Hepatology International|November 1, 2023
Why is the functional cure rate of young children with chronic hepatitis B receiving antiviral therapy considerably high?Fu-Sheng Wang, Jing Li, Chao Zhang
Cellular & Molecular Immunology|November 7, 2020
Neutrophils in liver diseases: pathogenesis and therapeutic targetsKai Liu, Fu-Sheng Wang, Ruonan Xu
The Lancet. Gastroenterology & Hepatology|March 8, 2020
Liver injury in COVID-19: management and challengesChao Zhang, Lei Shi, Fu-Sheng Wang
Alimentary Pharmacology & Therapeutics|January 10, 2024
Letter: Baseline age on antiviral treatment may significantly influence the clinical response of children with chronic hepatitis BJing Li, Yaxin Wu, Fu-Sheng Wang
Cellular & Molecular Immunology|December 14, 2011
Liver fibrosis: mechanisms of immune-mediated liver injuryRuonan Xu, Zheng Zhang, Fu-Sheng Wang
The New England Journal of Medicine|March 27, 2004
SARS-associated coronavirus quasispecies in individual patientsDongping Xu, Zheng Zhang, Fu-Sheng Wang
Infectious Diseases & Immunity|April 17, 2024
The Progress and Challenges of Convalescent Plasma Therapy for Coronavirus Disease 2019Ming Shi, Chao Zhang, Fu-Sheng Wang
Infectious Diseases & Immunity|June 22, 2026
Viral persistence in long COVID: Research advances and treatment strategiesShiyang Liu, Yuming Guo, Fu-Sheng Wang
The Lancet. HIV|June 1, 2020
COVID-19 in people with HIVZhe Xu, Chao Zhang, Fu-Sheng Wang
Ebiomedicine|March 13, 2022
Mesenchymal stem cell treatment for COVID-19Ruonan Xu, Zhiqian Feng, Fu-Sheng Wang
Pageof 43